MedTrace Logo

Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing

NCT02998112 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2016-12-20

No results posted yet for this study

Summary

To indicate the efficacy of Fecal microbiota transplantation (FMT) for the treatment of Ulcerative colitis (UC), The investigators design a multicenter, randomized controlled trial to perform FMT through colonic transendoscopic enteral tubing (TET) way, and evaluate the efficacy and safety of FMT for patients with moderate or severe UC.

Conditions

Interventions

DRUG

fecal microbiota transplantation

Fecal microbiota which was purified from fresh stool defecated by a healthy donor

DRUG

Saline

Sponsors & Collaborators

  • Air Force Military Medical University, China

    collaborator OTHER

  • First Hospital of Guangzhou

    collaborator UNKNOWN

  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

    collaborator OTHER

  • Zhongshan Hospital Xiamen University

    collaborator OTHER

  • The Second Hospital of Nanjing Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-07-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02998112 on ClinicalTrials.gov